Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control?

Flokas ME, Zeymo A, Mete M, Anhalt H, Rother KI, Gourgari E.

J Diabetes Complications. 2019 Dec 30:107513. doi: 10.1016/j.jdiacomp.2019.107513. [Epub ahead of print]

PMID:
32007420
2.
3.

SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks.

Taylor SI, Blau JE, Rother KI, Beitelshees AL.

Lancet Diabetes Endocrinol. 2019 Dec;7(12):949-958. doi: 10.1016/S2213-8587(19)30154-8. Epub 2019 Oct 1. Review.

PMID:
31585721
4.

Maternal Exposure to Non-nutritive Sweeteners Impacts Progeny's Metabolism and Microbiome.

Olivier-Van Stichelen S, Rother KI, Hanover JA.

Front Microbiol. 2019 Jun 20;10:1360. doi: 10.3389/fmicb.2019.01360. eCollection 2019.

5.

Low-calorie sweetener use, weight, and metabolic health among children: A mini-review.

Young J, Conway EM, Rother KI, Sylvetsky AC.

Pediatr Obes. 2019 Aug;14(8):e12521. doi: 10.1111/ijpo.12521. Epub 2019 Apr 14. Review.

PMID:
30983091
6.

Trends in Low-Calorie Sweetener Consumption Among Pregnant Women in the United States.

Sylvetsky AC, Figueroa J, Rother KI, Goran MI, Welsh JA.

Curr Dev Nutr. 2019 Jan 15;3(4):nzz004. doi: 10.1093/cdn/nzz004. eCollection 2019 Apr.

7.

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study.

Gourgari E, Playford MP, Campia U, Dey AK, Cogen F, Gubb-Weiser S, Mete M, Desale S, Sampson M, Taylor A, Rother KI, Remaley AT, Mehta NN.

Cardiovasc Diabetol. 2018 Dec 19;17(1):158. doi: 10.1186/s12933-018-0802-0.

8.

Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum.

Parker VER, Keppler-Noreuil KM, Faivre L, Luu M, Oden NL, De Silva L, Sapp JC, Andrews K, Bardou M, Chen KY, Darling TN, Gautier E, Goldspiel BR, Hadj-Rabia S, Harris J, Kounidas G, Kumar P, Lindhurst MJ, Loffroy R, Martin L, Phan A, Rother KI, Widemann BC, Wolters PL, Coubes C, Pinson L, Willems M, Vincent-Delorme C; PROMISE Working Group, Vabres P, Semple RK, Biesecker LG.

Genet Med. 2019 May;21(5):1189-1198. doi: 10.1038/s41436-018-0297-9. Epub 2018 Oct 1.

9.

How Non-nutritive Sweeteners Influence Hormones and Health.

Rother KI, Conway EM, Sylvetsky AC.

Trends Endocrinol Metab. 2018 Jul;29(7):455-467. doi: 10.1016/j.tem.2018.04.010. Epub 2018 May 30. Review.

PMID:
29859661
10.

Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study.

Blau JE, Bauman V, Conway EM, Piaggi P, Walter MF, Wright EC, Bernstein S, Courville AB, Collins MT, Rother KI, Taylor SI.

JCI Insight. 2018 Apr 19;3(8). pii: 99123. doi: 10.1172/jci.insight.99123. eCollection 2018 Apr 19.

11.

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R.

J Clin Invest. 2018 Jul 2;128(7):3041-3052. doi: 10.1172/JCI98814. Epub 2018 Jun 11.

12.

Nonnutritive Sweeteners in Weight Management and Chronic Disease: A Review.

Sylvetsky AC, Rother KI.

Obesity (Silver Spring). 2018 Apr;26(4):635-640. doi: 10.1002/oby.22139. Review.

13.

Factitious hypoglycemia in children and adolescents with diabetes.

Bauman V, Sturkey AC, Sherafat-Kazemzadeh R, McEwan J, Jones PM, Keating A, Isganaitis E, Ricker A, Rother KI.

Pediatr Diabetes. 2018 Jun;19(4):823-831. doi: 10.1111/pedi.12650. Epub 2018 Feb 21. Review.

14.

Response to 'Letter to the Editor: regarding Sylvetsky et al. 2017 Plasma concentrations of sucralose in children and adults'.

Meni Sylvetsky AC, Rother KI.

Toxicol Environ Chem. 2017;99(4):732-733. doi: 10.1080/02772248.2017.1288317. Epub 2017 Mar 1. No abstract available.

15.

Low-Calorie Sweeteners: Disturbing the Energy Balance Equation in Adolescents?

Sylvetsky AC, Jin Y, Mathieu K, DiPietro L, Rother KI, Talegawkar SA.

Obesity (Silver Spring). 2017 Dec;25(12):2049-2054. doi: 10.1002/oby.22005. Epub 2017 Oct 31.

16.

Pharmacokinetics of Sucralose and Acesulfame-Potassium in Breast Milk Following Ingestion of Diet Soda.

Rother KI, Sylvetsky AC, Walter PJ, Garraffo HM, Fields DA.

J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):466-470. doi: 10.1097/MPG.0000000000001817.

17.

A High-Carbohydrate, High-Fiber, Low-Fat Diet Results in Weight Loss among Adults at High Risk of Type 2 Diabetes.

Sylvetsky AC, Edelstein SL, Walford G, Boyko EJ, Horton ES, Ibebuogu UN, Knowler WC, Montez MG, Temprosa M, Hoskin M, Rother KI, Delahanty LM; Diabetes Prevention Program Research Group.

J Nutr. 2017 Nov;147(11):2060-2066. doi: 10.3945/jn.117.252395. Epub 2017 Sep 27.

18.

Development of Sweet Taste Perception: Implications for Artificial Sweetener Use.

Sylvetsky AC, Conway EM, Malhotra S, Rother KI.

Endocr Dev. 2017;32:87-99. doi: 10.1159/000475733. Epub 2017 Aug 15. Review.

PMID:
28873386
19.

Plasma concentrations of sucralose in children and adults.

Sylvetsky AC, Bauman V, Blau JE, Garraffo HM, Walter PJ, Rother KI.

Toxicol Environ Chem. 2017;99(3):535-542. doi: 10.1080/02772248.2016.1234754. Epub 2016 Oct 17.

20.

Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.

Blau JE, Tella SH, Taylor SI, Rother KI.

Diabetes Metab Res Rev. 2017 Nov;33(8). doi: 10.1002/dmrr.2924. Epub 2017 Sep 29.

Supplemental Content

Loading ...
Support Center